Psychedelic stocks rise as FDA chief’s comments seen favorable to industry

1 month ago 2

• Healthcare
• On the Move

JHVEPhoto

Companies focused on psychedelic medicines traded higher for the second straight session on Tuesday after FDA Commissioner Marty Makary said evaluating the potential of psilocybin, MDMA, and other psychedelics will be a “top priority” under the Trump administration.

“People have

Recommended For You

More Trending News

See More »

1. Homepage
2. Politics
3. Psychedelic stocks rise as FDA chief’s comments seen favorable to industry